Corixa's P2P Acquisition

Corixa raised a round of funding on May 20, 2010. Investors include GlaxoSmithKline.

Corixa is a biopharmaceutical company that develops oncology and immunology products that manage human diseases. The company is focused on immunotherapeutic products and has a broad technology platfor…

Articles about Corixa's P2P Acquisition: